246 related articles for article (PubMed ID: 10393455)
1. Nail changes secondary to docetaxel (Taxotere).
Correia O; Azevedo C; Pinto Ferreira E; Braga Cruz F; Polónia J
Dermatology; 1999; 198(3):288-90. PubMed ID: 10393455
[TBL] [Abstract][Full Text] [Related]
2. Taxane-induced nail changes: incidence, clinical presentation and outcome.
Minisini AM; Tosti A; Sobrero AF; Mansutti M; Piraccini BM; Sacco C; Puglisi F
Ann Oncol; 2003 Feb; 14(2):333-7. PubMed ID: 12562663
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel-induced subungual hemorrhage.
Vanhooteghem O; André J; Vindevoghel A; Vandenbossche L; Vandeveire A; Song M
Dermatology; 1997; 194(4):419-20. PubMed ID: 9252781
[TBL] [Abstract][Full Text] [Related]
4. Docetaxel-induced nail dystrophy.
Nicolopoulos J; Howard A
Australas J Dermatol; 2002 Nov; 43(4):293-6. PubMed ID: 12423438
[TBL] [Abstract][Full Text] [Related]
5. Clinical picture: nail changes secondary to docetaxel.
Wasner G; Hilpert F; Baron R; Pfisterer J
Lancet; 2001 Mar; 357(9260):910. PubMed ID: 11289346
[No Abstract] [Full Text] [Related]
6. Docetaxel chemotherapy induces transverse superficial loss of the nail plate.
Llombart-Cussac A; Pivot X; Spielmann M
Arch Dermatol; 1997 Nov; 133(11):1466-7. PubMed ID: 9371043
[No Abstract] [Full Text] [Related]
7. Docetaxel-related skin, nail, and vascular toxicity.
Leonard GD; Zujewski JA
Ann Pharmacother; 2003 Jan; 37(1):148. PubMed ID: 12564432
[No Abstract] [Full Text] [Related]
8. Subungueal haemorrhages following docetaxel (taxotere) treatment.
Fenniche S; Hammami H; Badri T; Mokhtar I; Benmously R
Curr Drug Saf; 2012 Jul; 7(3):247-9. PubMed ID: 22950986
[TBL] [Abstract][Full Text] [Related]
9. [Yellow nails].
Auvinet M; Dahan S; Dingremont C; Ollier S; Juchet H; Arlet P
Rev Med Interne; 1998 May; 19(5):353-4. PubMed ID: 9775172
[No Abstract] [Full Text] [Related]
10. Subungual abscess: a new ungual side-effect related to docetaxel therapy.
Vanhooteghem O; Richert B; Vindevoghel A; Vandenbossche L; Vandeveire A; de la Brassinne M
Br J Dermatol; 2000 Aug; 143(2):462-4. PubMed ID: 10951175
[No Abstract] [Full Text] [Related]
11. Onycholysis in patients treated with docetaxel.
Obermair A; Binder M; Barrada M; Bancher-Todesca D; Asseryanis E; Kubista E
Ann Oncol; 1998 Feb; 9(2):230-1. PubMed ID: 9553674
[No Abstract] [Full Text] [Related]
12. Nail changes due to docetaxel.
Pavithran K; Doval DC
Br J Dermatol; 2002 Apr; 146(4):709-10. PubMed ID: 11966714
[No Abstract] [Full Text] [Related]
13. Paclitaxel-related nail toxicity.
Yang ST; Cheng M; Lee NR; Chang WH; Lee YL; Wang PH
Taiwan J Obstet Gynecol; 2019 Sep; 58(5):709-711. PubMed ID: 31542098
[TBL] [Abstract][Full Text] [Related]
14. Nail toxicity related to taxanes.
Mourad YA; Matta-Muallem M; Shamseddine A
Dermatol Online J; 2003 Aug; 9(3):15. PubMed ID: 12952762
[TBL] [Abstract][Full Text] [Related]
15. Nail bed dyschromia secondary to docetaxel therapy.
Jacob CI; Patten SF
Arch Dermatol; 1998 Sep; 134(9):1167-8. PubMed ID: 9762045
[No Abstract] [Full Text] [Related]
16. Docetaxel-induced nail changes--a neurogenic mechanism: a case report.
Wasner G; Hilpert F; Schattschneider J; Binder A; Pfisterer J; Baron R
J Neurooncol; 2002 Jun; 58(2):167-74. PubMed ID: 12164689
[TBL] [Abstract][Full Text] [Related]
17. Nail alterations secondary to pactitaxel [corrected] therapy.
Almagro M; Pozo JD; Garcia J; Vasquez A; Fonseca E
Eur J Dermatol; 2000 Mar; 10(2):146-7. PubMed ID: 10694317
[TBL] [Abstract][Full Text] [Related]
18. Docetaxel (Taxotere) for advanced breast cancer.
Med Lett Drugs Ther; 1996 Sep; 38(984):87-8. PubMed ID: 8828520
[No Abstract] [Full Text] [Related]
19. [Onycholysis due to docetaxel in breast cancer treatment].
Grasland A; Grandjean M; Rist S; Bosquet A; Vinceneux P
Rev Med Interne; 2005 May; 26(5):427-8. PubMed ID: 15893036
[No Abstract] [Full Text] [Related]
20. Docetaxel.
Leahy M; Howell A
Br J Hosp Med; 1997 Feb 19-Mar 4; 57(4):141-4. PubMed ID: 9166374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
